Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Erhan Ararat

Concepts (102)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

The timeline below shows the dates (blue tick marks) of publications associated with Erhan Ararat's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Erhan Ararat has written about over time.
Angiotensin II Type 1 Receptor Blockers, 1 publications between 2009 and 2009, average publication date April 2009. Losartan, 1 publications between 2009 and 2009, average publication date April 2009. Mitogen-Activated Protein Kinase 1, 1 publications between 2009 and 2009, average publication date April 2009. Mitogen-Activated Protein Kinase 3, 1 publications between 2009 and 2009, average publication date April 2009. Protein Phosphatase 1, 1 publications between 2009 and 2009, average publication date April 2009. Anti-Inflammatory Agents, Non-Steroidal, 1 publications between 2010 and 2010, average publication date July 2010. Neoplasm Metastasis, 1 publications between 2010 and 2010, average publication date July 2010. Diphosphonates, 1 publications between 2010 and 2010, average publication date September 2010. Imidazoles, 1 publications between 2010 and 2010, average publication date September 2010. Aspirin, 2 publications between 2010 and 2011, average publication date October 2010. Antineoplastic Combined Chemotherapy Protocols, 3 publications between 2010 and 2011, average publication date December 2010. Breast Neoplasms, 11 publications between 2010 and 2015, average publication date September 2011. Neoadjuvant Therapy, 3 publications between 2011 and 2013, average publication date December 2011. Lung, 3 publications between 2015 and 2022, average publication date December 2019. Cystic Fibrosis, 1 publications between 2021 and 2021, average publication date July 2021. Diabetes Mellitus, 1 publications between 2021 and 2021, average publication date July 2021. Organoids, 2 publications between 2022 and 2022, average publication date March 2022. Anti-Asthmatic Agents, 1 publications between 2023 and 2023, average publication date September 2023. Asthma, 1 publications between 2023 and 2023, average publication date September 2023. Metformin, 1 publications between 2023 and 2023, average publication date September 2023.

To see the data from this visualization as text, click here.
Ararat's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description